Page last updated: 2024-10-24

regulation of systemic arterial blood pressure by endothelin

Definition

Target type: biologicalprocess

The process in which endothelin modulates the force with which blood passes through the circulatory system. Endothelin is a hormone that is released by the endothelium, and it is a vasoconstrictor. [GOC:mtg_cardio]

Endothelin, a potent vasoconstrictor peptide, plays a crucial role in regulating systemic arterial blood pressure. It is primarily produced by vascular endothelial cells and exerts its effects through binding to two G protein-coupled receptors, endothelin receptor A (ETu003csubu003eAu003c/subu003e) and endothelin receptor B (ETu003csubu003eBu003c/subu003e).

The regulation of systemic arterial blood pressure by endothelin involves a complex interplay of multiple mechanisms:

1. **Direct Vasoconstriction:**
- Endothelin, particularly through its interaction with ETu003csubu003eAu003c/subu003e receptors, causes potent vasoconstriction in systemic arteries, leading to an increase in peripheral resistance and ultimately, elevation of blood pressure.
- This effect is mediated by the activation of intracellular signaling pathways involving phospholipase C, inositol triphosphate, and calcium mobilization, culminating in the contraction of vascular smooth muscle cells.

2. **Modulation of Vascular Tone:**
- Endothelin can also indirectly influence vascular tone by affecting the release of other vasoactive substances.
- For example, it can stimulate the production of nitric oxide (NO), a potent vasodilator, through a complex feedback mechanism involving ETu003csubu003eBu003c/subu003e receptors and the activation of endothelial nitric oxide synthase (eNOS).
- However, this vasodilatory effect is often overshadowed by the dominant vasoconstrictive action mediated by ETu003csubu003eAu003c/subu003e receptors.

3. **Regulation of Renin-Angiotensin System:**
- Endothelin can interact with the renin-angiotensin system, a key player in blood pressure regulation.
- It can stimulate the release of renin, the enzyme responsible for initiating the cascade that leads to the formation of angiotensin II, a potent vasoconstrictor and aldosterone-stimulating hormone.
- This further contributes to the elevation of blood pressure.

4. **Influence on Sodium and Water Balance:**
- Endothelin can also influence sodium and water balance by affecting renal function.
- It can promote sodium reabsorption in the proximal tubules, leading to an increase in blood volume and further contributing to blood pressure elevation.

5. **Neuroendocrine Regulation:**
- Endothelin can also interact with the central nervous system, influencing the release of neurotransmitters and hormones that modulate cardiovascular function.
- For instance, it can stimulate the release of vasopressin, a potent vasoconstrictor and antidiuretic hormone, further contributing to the elevation of blood pressure.

In summary, endothelin, through its interaction with specific receptors and its influence on various signaling pathways, exerts a potent vasoconstrictive effect, modulates vascular tone, interacts with the renin-angiotensin system, influences sodium and water balance, and impacts neuroendocrine regulation, thereby playing a significant role in the regulation of systemic arterial blood pressure. This complex interplay of mechanisms underscores the importance of endothelin in the maintenance of cardiovascular homeostasis.'
"

Proteins (3)

ProteinDefinitionTaxonomy
Transforming protein RhoAA GTP-binding protein RhoA that is encoded in the genome of human. [PRO:CNA, UniProtKB:P61586]Homo sapiens (human)
Endothelin-converting enzyme 1An endothelin-converting enzyme 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P42892]Homo sapiens (human)
Nitric oxide synthase, endothelialA nitric oxide synthase 3 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P29474]Homo sapiens (human)

Compounds (30)

CompoundDefinitionClassesRoles
n-(3-(aminomethyl)benzyl)acetamidineN-(3-(aminomethyl)benzyl)acetamidine: structure in first source

N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
aralkylamine;
carboxamidine;
primary amino compound
angiogenesis inhibitor;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
geroprotector
2-amino-4-picoline2-amino-4-picoline: RN given refers to parent cpd
7-nitroindazole7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure
pimagedineaminoguanidine : A one-carbon compound whose unique structure renders it capable of acting as a derivative of hydrazine, guanidine or formamide.

pimagedine: diamine oxidase & nitric oxide synthase inhibitor; an advanced glycosylation end product inhibitor; used in the treatment of diabetic complications; structure
guanidines;
one-carbon compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
thiorphanThiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.N-acyl-amino acid
etironetiron: a nitric oxide synthase inhibitor; RN given refers to parent cpd; structure
s-methylisothiopseudouroniumS-methylisothiopseudouronium: inhibits nitric oxide synthase; structure in first source
alpha-aminopyridinealpha-aminopyridine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #485

aminopyridine : Compounds containing a pyridine skeleton substituted by one or more amine groups.
2-amino-3-methylpyridine2-amino-3-methylpyridine: structure in first source
2-aminothiazoline2-aminothiazoline: RN given refers to parent cpd; structure in first source & in Negwer, 5th ed, #97

4,5-dihydro-1,3-thiazol-2-amine : A 1,3-thiazole that is 4,5-dihydro-1,3-thiazole substituted by an amino group at position 2.
1,3-thiazoles;
primary amino compound
ng-nitroarginine methyl esterNG-Nitroarginine Methyl Ester: A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension.alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor
captoprilcaptopril : A L-proline derivative in which L-proline is substituted on nitrogen with a (2S)-2-methyl-3-sulfanylpropanoyl group. It is used as an anti-hypertensive ACE inhibitor drug.

Captopril: A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
1-aminoisoquinoline
s-methylthiocitrullineS-methyl-L-thiocitrulline : An L-arginine derivative in which the guanidino NH2 group of L-arginine is replaced by a methylsufanyl group.

S-methylthiocitrulline: a nitric oxide synthase inhibitor; structure in first source
imidothiocarbamic ester;
L-arginine derivative;
L-ornithine derivative;
non-proteinogenic L-alpha-amino acid
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
neuroprotective agent
n(g)-iminoethylornithineL-alpha-amino acid
2-(4-morpholinyl)-4h-1-benzopyran-4-one2-(4-morpholinyl)-4H-1-benzopyran-4-one: an aminochromone; exhibits both antiproliferative and antichemotactic activity in vitro
omega-n-methylarginineN(omega)-methyl-L-arginine : A L-arginine derivative with a N(omega)-methyl substituent.

omega-N-Methylarginine: A competitive inhibitor of nitric oxide synthetase.
amino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
cgs 26303CGS 26303: a potent non-peptidic inhibitor of neutral endopeptidase capable of protecting atrial natriuretic peptide from enzymatic degradation; structure given in first source
ng-nitroarginine methyl esterN(gamma)-nitro-L-arginine methyl ester hydrochloride : A hydrochloride obtained by combining N(gamma)-nitro-L-arginine methyl ester with one equivalent of hydrochloric acid.hydrochlorideEC 1.14.13.39 (nitric oxide synthase) inhibitor
delta-n-methylarginineN(5)-methyl-L-arginine : A non-proteinogenic L-alpha-amino acid that is L-arginine substituted by a methyl group at N(5)-position.guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
2-amino-5,6-dihydro-4h-1,3-thiazine2-amino-5,6-dihydro-4H-1,3-thiazine: RN given refers to parent cpd
nitroarginineN(gamma)-nitro-L-arginine : An L-arginine derivative that is L-arginine in which the terminal nitrogen of the guanidyl group is replaced by a nitro group.

Nitroarginine: An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
guanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
phosphoramidonphosphoramidon : A dipeptide isolated from the cultures of Streptomyces tanashiensis.

phosphoramidon: a membrane metallo-endopeptidase & endothelin-converting enzyme inhibitor; thermolysin inhibitor from culture filtrate of Streptomyces tanashiensis; structure
deoxyaldohexose phosphate;
dipeptide
bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
arl 17477
n(6)-(1-iminoethyl)lysineN(6)-acetimidoyl-L-lysine : An L-lysine derivative that is L-lysine in which one of the hydrogens attached to N(6) is substituted by an acetimidoyl groupL-lysine derivative;
non-proteinogenic L-alpha-amino acid
benzyloxycarbonyl-phe-ala-fluormethylketonecathepsin B inhibitor : A cysteine protease inhibitor which inhibits cathepsin B (EC 3.4.22.1).
gw 274150
cgs 35066CGS 35066: an endothelin-converting enzyme-1 inhibitor; structure in first source
s 3304S 3304: structure in first source
ccg-203971